Concepedia

Haemodynamic and pharmacological effects of the converting enzyme inhibitor CGS 14824A in normal volunteers

M. D. Schaller, J. Nussberger, Bernard Waeber, J. P. Bussien, G. A. Turini, H. Brünner, Hans R. Brunner

European Journal of Clinical Pharmacology · 1985 · 33 citations · 22 references

Concepts

MedicinePharmacologyPharmacotherapyClinical PharmacologyDrug MetabolismPharmacodynamicsEnzyme InhibitionEnzyme KineticsDrug-induced Enzyme AlterationsEnzyme-inhibitor BindingPharmacological TherapyTherapeutic Drug Effects On Enzyme LevelsTherapeutic Drug Effects On Enzymes

References

22

Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in Man

Haralambos Gavras, Hans R. Brunner, G. A. Turini et al. · New England Journal of Medicine · 1978 · 608 citations

Medicine, Pharmacology, Pharmacotherapy +16

Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients

David B. Case, Steven A. Atlas, John H. Laragh et al. · Progress in Cardiovascular Diseases · 1978 · 366 citations

Medicine, Cardiology, Pharmacology +16

Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive Patients

Hans R. Brunner · Annals of Internal Medicine · 1979 · 358 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

A SPECIFIC ORALLY ACTIVE INHIBITOR OF ANGIOTENSIN-CONVERTING ENZYME IN MAN

RogerK. Ferguson, Hans-R. Brunner, GustaveA. Turini et al. · The Lancet · 1977 · 325 citations

Medicine, Pharmacology, Pharmacotherapy +10

Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.

Robert Ader, Kanu Chatterjee, Thomas A. Ports et al. · Circulation · 1980 · 292 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17